Cargando…

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis

Background: Cancer-specific survival (CSS) within high-risk non-metastatic prostate cancer varies dramatically. It is likely that within this heterogenous population there are subgroup(s) at extraordinary risk, burdened with an exaptational poor prognosis. Establishing the characteristics of these g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chys, Brecht, Devos, Gaëtan, Everaerts, Wouter, Albersen, Maarten, Moris, Lisa, Claessens, Frank, De Meerleer, Gert, Haustermans, Karin, Briganti, Alberto, Chlosta, Piotr, Gontero, Paolo, Graefen, Markus, Gratzke, Christian, Karnes, R. Jeffrey, Kneitz, Burkhard, Marchioro, Giansilvio, Salas, Rafael Sanchez, Spahn, Martin, Tombal, Bertrand, Van Der Poel, Henk, Walz, Jochen, Van Poppel, Hendrik, Joniau, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068909/ https://www.ncbi.nlm.nih.gov/pubmed/32211317 http://dx.doi.org/10.3389/fonc.2020.00246

Ejemplares similares

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis
por: Schubert, Maria, et al.
Publicado: (2012)

Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news
por: Berghen, Charlien, et al.
Publicado: (2020)

Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial
por: Berghen, Charlien, et al.
Publicado: (2020)

Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
por: Devos, Gaëtan, et al.
Publicado: (2019)

Comparison of Functional Outcome after Extended versus Super-Extended Pelvic Lymph Node Dissection during Radical Prostatectomy in High-Risk Localized Prostate Cancer
por: Seikkula, Heikki, et al.
Publicado: (2017)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis
por: Veys, Ralf, et al.
Publicado: (2017)

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
por: Tosco, Lorenzo, et al.
Publicado: (2018)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
por: Van Baelen, Anthony, et al.
Publicado: (2012)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
por: Devos, Gaëtan, et al.
Publicado: (2020)

DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
por: Litovkin, Kirill, et al.
Publicado: (2015)

Preclinical Evidence for the Benefits of Penile Rehabilitation Therapy following Nerve-Sparing Radical Prostatectomy
por: Albersen, M., et al.
Publicado: (2008)

Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer
por: Schubert, Maria, et al.
Publicado: (2013)

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
por: Marra, Giancarlo, et al.
Publicado: (2022)

Penile metastasis in prostate cancer patients: Two case reports, surgical excision technique, and literature review
por: Landen, Lucas, et al.
Publicado: (2023)

MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
por: Kalogirou, Charis, et al.
Publicado: (2013)

Cardiovascular risk during hormonal treatment in patients with prostate cancer
por: Van Poppel, Hein, et al.
Publicado: (2011)

Radical Prostatectomy and Intraoperative Radiation Therapy in High-Risk Prostate Cancer
por: Marchioro, Giansilvio, et al.
Publicado: (2012)

Metastasectomy of oligometastatic urothelial cancer: a single-center experience
por: Muilwijk, Tim, et al.
Publicado: (2020)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Comparison of postoperative complications of ileal conduits versus orthotopic neobladders
por: Demaegd, Liesbeth, et al.
Publicado: (2020)

Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2021)

The Role of Single Nucleotide Polymorphisms in Predicting Prostate Cancer Risk and Therapeutic Decision Making
por: Van den Broeck, Thomas, et al.
Publicado: (2014)

Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2020)

PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
por: Devos, Gaëtan, et al.
Publicado: (2020)

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
por: Eckhardt, Carolin, et al.
Publicado: (2021)

Risk stratification tools in prostate cancer, where do we stand?
por: Clinckaert, Andries, et al.
Publicado: (2021)

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023)

The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients
por: Gevaert, Thomas, et al.
Publicado: (2020)

Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
por: Junius, Sara, et al.
Publicado: (2007)

The N-shaped orthotopic ileal neobladder: functional outcomes and complication rates in 119 patients
por: De Sutter, Thomas, et al.
Publicado: (2016)

Chemoprevention of prostate cancer with nutrients and supplements
por: Van Poppel, Hendrik, et al.
Publicado: (2011)

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
por: Giesen, Alexander, et al.
Publicado: (2023)

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer
por: Bravi, Carlo A., et al.
Publicado: (2022)

Surveillance as an Option for the Treatment of Small Renal Masses
por: Klaver, S., et al.
Publicado: (2008)

Comparing the rules of engagement of androgen and glucocorticoid receptors
por: Claessens, Frank, et al.
Publicado: (2017)

Parameters predicting [(18)F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021)

Uro-oncology in the era of social distancing: the principles of patient-centered online consultations during the COVID-19 pandemic
por: Sosnowski, Roman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_400sb1oelnfhdluvdtoodp1d7k